CRA was retained in an international arbitration between two Japanese affiliates of multinational pharmaceutical companies. The dispute concerned Respondent’s performance under a co-promotion agreement. CRA assessed indicators of commercially reasonable efforts using various industry data sources. CRA also quantified Claimant’s loss resulting from the alleged inadequate performance under the agreement, and responded to Respondent’s expert regarding damages alleged by Respondent.
Renewable Energy Disputes in the Americas: Potential Future Developments
The annual report contains insight and thought leadership inspired by the recent past from 43 pre-eminent practitioners. All contributors are vetted for their...